Home›Stocks›OCUL

OCUL — structural market context

Ocular Therapeutix, Inc. Commo

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

OCUL short interest & days to cover

SHARES SHORT

26.7M

% OF FLOAT

—

DAYS TO COVER

13.5

CHANGE VS PRIOR

-1.1%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (27d ago)

OCUL fails-to-deliver (FTD)

Settlement date	Failed shares	Price
2026-07-29 · 29d	35	$8.45
2026-07-28 · 30d	14K	$8.64
2026-07-22 · 36d	9K	$8.93

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

OCUL insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 4 sales

Insider	Type	Shares	Value	Filed
Kaiser Peter · officer: Chief Development Officer	Sell (S)	3K	$33K	2026-08-26
Nayak Sanjay · officer: Chief Strategy Officer	Sell (S)	2K	$20K	2026-08-26
Heier Jeffrey S. · officer: Chief Scientific Officer	Sell (S)	3K	$36K	2026-08-26
Dugel Pravin · director, officer: See Remarks	Sell (S)	22K	$233K	2026-08-26

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying OCUL?

In the last 12 months of SEC Form 4 filings, OCUL recorded 0 open-market insider purchases and 4 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.

Is this page telling me to buy or sell OCUL?

No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.

All covered stocks Short Interest & FTD tracker Insider Buying tracker The platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.